TRIKAFTA Trademark

Trademark Overview

On Wednesday, April 25, 2018, a trademark application was filed for TRIKAFTA with the United States Patent and Trademark Office. The USPTO has given the TRIKAFTA trademark a serial number of 87893193. The federal status of this trademark filing is REGISTERED as of Tuesday, December 17, 2019. This trademark is owned by Vertex Pharmaceuticals Incorporated. The TRIKAFTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cystic fibrosis
trikafta

General Information

Serial Number87893193
Word MarkTRIKAFTA
Filing DateWednesday, April 25, 2018
Status700 - REGISTERED
Status DateTuesday, December 17, 2019
Registration Number5938914
Registration DateTuesday, December 17, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 21, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cystic fibrosis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 4, 2018
Primary Code005
First Use Anywhere DateMonday, October 28, 2019
First Use In Commerce DateMonday, October 28, 2019

Trademark Owner History

Party NameVertex Pharmaceuticals Incorporated
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameVertex Pharmaceuticals Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameVertex Pharmaceuticals Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events

Event DateEvent Description
Friday, May 4, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 16, 2018ASSIGNED TO EXAMINER
Saturday, April 28, 2018NEW APPLICATION ENTERED
Wednesday, August 1, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 21, 2018PUBLISHED FOR OPPOSITION
Wednesday, October 16, 2019SOU TEAS EXTENSION RECEIVED
Wednesday, July 18, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 21, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 16, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 15, 2019SOU TEAS EXTENSION RECEIVED
Monday, April 15, 2019SOU EXTENSION 1 FILED
Monday, April 15, 2019SOU EXTENSION 1 GRANTED
Wednesday, April 17, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 18, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 29, 2019TEAS STATEMENT OF USE RECEIVED
Tuesday, October 29, 2019USE AMENDMENT FILED
Saturday, November 9, 2019STATEMENT OF USE PROCESSING COMPLETE
Tuesday, December 17, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, October 16, 2019SOU EXTENSION 2 FILED
Wednesday, October 16, 2019SOU EXTENSION 2 GRANTED
Saturday, November 9, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 12, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, November 13, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 23, 2025TEAS SECTION 8 & 15 RECEIVED
Tuesday, December 17, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

trikafta fibrosis cystic treatment preparations pharmaceutical